This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

David Entwistle, Ph.D.
Sr Director, Program & Pipeline Management at Codexis
Speaker

Profile

David is a synthetic organic chemist who obtained his Ph.D in 1994 under Prof. Steve Ley FRS. David’s postdoctoral positions with Prof Tomas Hudlicky and Prof. Gerry Pattenden FRS focused on synthetic organic methodologies and total synthesis. David began his industrial career in 1998 at Pfizer Process Chemistry, UK, working on many early to mid-clinical phase APIs. In 2012 David joined Codexis, Redwood City, USA where he led the process chemistry department. He has conceived and had oversight of many diverse enzyme screening and engineering projects across pharma other enzyme applications. Many of these programs have culminated in implemented commercial processes at the client’s sites.

At this event